Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Pfizer is likely to show GSK significant competition
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Subscribe To Our Newsletter & Stay Updated
